M&E Biotechnology (Mebio)

Mebio is a research based biotech company founded in 1990 and is specialized in the development of therapeutic vaccines against chronic inflammatory diseases and cancer. The Company has so far developed an anti-inflammatory product which will enter clinical trials within the next 9 months. In the Companys development program are several other therapeutic vaccines based on its proprietary AutoVac technology. Another platform technology of the Company, is the CellScreen technology, which is used for identification of novel drug targets for develpment of drugs against inflammation and cancer. The Company employs currently 23, 13 of these are PhD´s.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: